Psychiatry AtlasMedication guide · United States

Antidepressant that acts on serotonin and norepinephrine, two brain messengers

Venlafaxine (Effexor XR, Effexor)

Generic name
venlafaxine (as venlafaxine hydrochloride)
Brand names
Effexor XR; Effexor
Medication class
SNRI antidepressant
Forms covered
Extended-release oral capsules; Immediate-release oral tablets

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

  • Effexor can be confused with Effexor XR (U.S. official label). These are different release formulations of the same active medication; their names must not be treated as interchangeable.
  • Effexor XR can be confused with Enablex.

FDA Boxed Warning

Effexor XR extended-release oral capsules; Venlafaxine immediate-release oral tablets.

Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Monitor everyone taking venlafaxine for worsening symptoms or emerging suicidal thoughts, especially when treatment starts or the dose changes. This medicine is not approved for children.

Venlafaxine treats major depression; extended-release capsules also treat generalized anxiety, social anxiety, and panic disorder in adults. Immediate-release tablets and Effexor XR capsules have different schedules and approvals.

Effexor (original immediate-release brand discontinued).

What to expect: Full benefit may take several weeks or longer.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Major depressive disorder — Adults. Both selected formulations have adult depression labeling; their schedules and dose limits differ.Extended-release oral capsules; Immediate-release oral tablets.
  • Generalized anxiety disorder — Adults. This FDA indication belongs to Effexor XR in the article’s scope, not the immediate-release tablet label.Extended-release oral capsules.
  • Social anxiety disorder — Adults. The extended-release capsule label supports this indication.Extended-release oral capsules.
  • Panic disorder — Adults. The extended-release capsule label supports this indication.Extended-release oral capsules.

Other uses (off-label)

Off-label means a medicine is prescribed for a use, age group or form that is not included in its FDA approval.

  • Menopausal hot flashes — Adults. MedlinePlus describes use for hot flashes; this is not an FDA-approved venlafaxine indication and is not a treatment recommendation.Extended-release oral capsules; Immediate-release oral tablets.

What should I expect?

Full benefit may take several weeks or longer. Track changes in the depressive or anxiety symptoms being treated, while also noticing sleep, sexual effects, and ability to manage daily activities.

Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.

How do I take it safely?

Take Effexor XR once daily with food at a consistent time. Swallow whole, or use the label’s option to put all capsule contents on a spoonful of applesauce, swallow immediately without chewing, and follow with water. Do not divide, crush, or put pellets in water.

Immediate-release tablets are taken with food in divided doses as prescribed. Do not convert between forms yourself. Blood pressure needs checking before and during treatment; kidney or liver problems may change the plan.

MAOI combinations are contraindicated. At least 14 days after an MAOI and at least seven days after venlafaxine before an MAOI are required by the labels; a clinician must manage these separations, including urgent treatment involving linezolid or intravenous methylene blue.

MAOIs without the required label separation, including relevant linezolid or intravenous methylene blue treatment. Hypersensitivity to venlafaxine or ingredients; Effexor XR also lists desvenlafaxine hypersensitivity.

High blood pressure should be controlled before treatment. Review bipolar episodes, seizures, narrow eye angles, bleeding, and low-sodium risk.

Other serotonergic drugs, including some opioids, triptans, lithium and certain supplements, increase serotonin-syndrome risk. Anticoagulants, aspirin and anti-inflammatory pain medicines can increase bleeding. CYP3A inhibitors and medicines processed by CYP2D6 may need review.

Avoid duplicate venlafaxine products and do not add desvenlafaxine as if it were merely another brand. Alcohol can worsen impairment. Venlafaxine can produce false-positive urine screening results for some substances; a confirmatory laboratory method is needed to interpret such a result.

In pregnancy, the balance includes untreated illness, possible postpartum bleeding and newborn adaptation problems following late exposure. Discuss treatment planning with the prescriber; an abrupt change can create its own risks.

Venlafaxine and ODV enter breast milk; monitor for infant sedation, poor feeding or poor weight gain. Neither scoped formulation is approved for children; pediatric studies raised growth, appetite and weight concerns. Older adults can be more vulnerable to low sodium, and declining kidney function may change dosing.

The label recommends gradual, individualized reduction, with monitoring. Dizziness, nausea, anxiety, sleep disturbance, electric-shock-like sensations and other reactions may occur, sometimes severely or for a long time; some patients need a reduction lasting months. These reactions do not establish addiction, but they are clinically important.

For a missed dose, the Medication Guide advises taking it when remembered unless the next dose is nearly due; then skip it. Do not take two doses together. Ask a pharmacist if the timing is uncertain.

What side effects should I know about?

  • Nausea, dry mouth, constipation and reduced appetite.
  • Sweating, sleepiness, dizziness or sleep changes.
  • Sexual difficulties, including ejaculation or orgasm problems.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Fever with agitation or confusion, sweating, diarrhea, muscle rigidity or twitching, and a fast heartbeat can be serotonin syndrome. Seek urgent medical care.
  • Seizures, severe confusion, major bleeding, painful vision changes or serious breathing symptoms need urgent assessment.
  • New suicidal thinking, possible mania or severe discontinuation symptoms require prompt clinical help.
  • Get emergency help for trouble breathing, collapse, a seizure, or severe or rapidly worsening symptoms. If thoughts of self-harm put you in immediate danger, seek emergency care now.

What else should I know to stay safe?

  • Do not use after a relevant allergy or with an MAOI without a clinician-managed interval: at least 14 days after an MAOI before venlafaxine and seven days after venlafaxine before an MAOI. Linezolid and intravenous methylene blue also matter. Effexor XR also lists desvenlafaxine allergy as a contraindication.
  • Control high blood pressure before treatment and measure it regularly. Review kidney or liver problems, bipolar episodes, seizures, glaucoma, low sodium, and bleeding. Other serotonin-affecting medicines, blood thinners, aspirin, anti-inflammatory medicines, and drugs that alter medicine breakdown need checking. Avoid duplicate products and do not add desvenlafaxine as another brand.
  • Abrupt stopping or substantial reductions can cause severe or prolonged withdrawal. Arrange a gradual, individualized plan with the prescriber. Alcohol can worsen impairment; urine drug screens may require confirmation of false-positive results.
  • Discuss pregnancy and breastfeeding, including postpartum bleeding and newborn adjustment concerns with late exposure. Monitor an exposed breastfed infant’s alertness, feeding, and weight. Neither covered form is approved for children; older adults need particular attention to low sodium and kidney function. Pediatric studies of the extended-release product found appetite loss, weight loss and potentially reduced height gain. If off-label treatment is considered, agree on follow-up for appetite, height, weight, blood pressure and mood.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • A late or missed dose can matter because withdrawal symptoms can occur after interruptions. If this happens, ask for help with a practical routine and a safe plan.
  • Blood-pressure checks are relevant even if you feel well. Venlafaxine can raise blood pressure without producing a clear warning symptom.

How does it work?

Venlafaxine slows the return of serotonin and norepinephrine, two chemical messengers, into the nerve cells that released them. The body also converts it into an active substance that has similar effects. These changes are thought to contribute to improvement in mood and anxiety, although the full explanation of that benefit remains uncertain.

Explore more in Brain & Science: How SNRIs Work: Venlafaxine.

How was this medicine developed?

Effexor XR received FDA approval in 1997 as an extended-release venlafaxine capsule. It allowed a different daily schedule from immediate-release tablets and has additional anxiety indications. The release form remains an important part of the prescription.

How do I say the name?

Venlafaxine: VEN-luh-fax-een. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Venlafaxine: patient information and pronunciation
  2. DailyMed: Effexor XR extended-release capsules
  3. DailyMed: venlafaxine immediate-release tablets
  4. Drugs@FDA: Effexor XR approval and product records
  5. FDA: Effexor XR prescribing information and Medication Guide
  6. Venlafaxine: Package Insert / Prescribing Information
  7. Drugs@FDA: original Effexor immediate-release approval and discontinuation status
  8. FDA: Zoloft prescribing information and Medication Guide
  9. FDA: Lexapro prescribing information and Medication Guide
  10. NIH: What Is a Neurotransmitter?
  11. PubChem: Venlafaxine parent compound and verified 2D record
  12. ISMP List of Confused Drug Names
  13. Effexor immediate-release reference prescribing information — FDA prescribing information
  14. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  15. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top